Arunjyoti Bio Ventures Ltd
Un-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
RESULTS
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 09 Jul 2026, 06:24 PM IST · BSE ID: 2b789255-e73f-4f53-9632-4254a9d3998d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a profit for the quarter, proposed a new company name, and revised salary for its directors, pending shareholder approval.
🤖 AI Summary
- Arunjyoti Bio Ventures reported a Net Profit after tax of INR 61.24 Lakhs for the quarter ended June 30, 2026.
- The Board approved a proposal to change the company's name from “Arunjyoti Bio Ventures Limited” to “Pasura Industries Limited,” subject to member approval.
- Remuneration for Mr. Badari Narayana Murthy Pabbathi was revised to Rs. 8,00,000 per month, plus Rs. 10,00,000 per annum Leave Travel allowance.
- Remuneration for Mr. Nadimpalli Vishal and Mr. Pabbathi Dathvik was revised to Rs. 5,00,000 per month each, plus Rs. 10,00,000 per annum Leave Travel allowance each.
- The company will seek member approval for waiver of recovery of excess managerial remuneration of Rs. 25.19 Lakhs for FY26.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit/(loss) after tax for the period / year (V-VI) Q1 FY27
61.24 INR Lakhs
Net Profit/(loss) after tax for the period / year (V-VI) Q4 FY26
(540.09) INR Lakhs
Net Profit/(loss) after tax for the period / year (V-VI) Q1 FY26
204.54 INR Lakhs
Revenue from operations Q1 FY27
820.00 INR Lakhs
Revenue from operations Q4 FY26
723.73 INR Lakhs
Waiver of excess managerial remuneration for FY26
25.19 INR Lakhs
🏢 How This Affects the Company
The proposed name change to “Pasura Industries Limited” may signify a strategic shift in business focus, subject to shareholder and regulatory approvals.
Net Profit after tax of INR 61.24 Lakhs for Q1 FY27 impacts the company's profitability. Revised remuneration for three Whole-time Directors will increase employee benefit expenses going forward.
Appointment of M/s. Vivek Surana & Associates as new secretarial auditors will ensure continuity of compliance and governance functions.
Seeking waiver for Rs. 25.19 Lakhs in excess managerial remuneration from FY26 introduces a governance risk, as it requires shareholder approval and addresses a prior period financial discrepancy.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to vote on the proposed name change, waiver of excess managerial remuneration, and secretarial auditor appointment at the 40th Annual General Meeting on August 12, 2026.
👤
Who Is Affected
All shareholders will be affected by the proposed name change and the financial implications of revised managerial remuneration and the waiver of INR 25.19 Lakhs in excess remuneration for FY26, if approved.
🔍
Management Signal
Management is signaling a potential strategic rebranding and a reevaluation of executive compensation, alongside addressing prior financial discrepancies through a waiver request.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Outcome of 40th Annual General Meeting on August 12, 2026 for key approvals.
Confirmation of company name change to Pasura Industries Limited after regulatory approvals.
Details on the business strategy following the proposed name change.
MEDIUM RISK
The waiver of excess managerial remuneration and significant remuneration revisions indicate governance risks and require shareholder approval.
💡 Investor Takeaway
Arunjyoti Bio Ventures reported Q1 FY27 Net Profit after tax of INR 61.24 Lakhs, compared to INR (540.09) Lakhs in Q4 FY26. The Board approved a proposed name change to "Pasura Industries Limited" and revised remuneration for three Whole-time Directors, subject to member approval.
⚖️ Strengths & Concerns
✅ Positives
- Company reported a Net Profit after tax of INR 61.24 Lakhs for Q1 FY27, a turnaround from the previous quarter's net loss of INR (540.09) Lakhs.
- Revenue from operations increased to INR 820.00 Lakhs for Q1 FY27, compared to INR 723.73 Lakhs in Q4 FY26.
⚠️ Concerns
- Net Profit after tax of INR 61.24 Lakhs for Q1 FY27 is lower than INR 204.54 Lakhs reported in the comparable Q1 FY26.
- The company is seeking shareholder approval to waive recovery of excess managerial remuneration of Rs. 25.19 Lakhs for FY26, indicating past remuneration irregularities.
📅 Company Track Record
Arunjyoti Bio Ventures reported INR 514.02 Lakhs net loss for FY26, widening from the prior year. The Board meeting for FY26 results approval was postponed by one day to May 13, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Arunjyoti Bio Ventures' Net Profit after tax for Q1 FY27?
Arunjyoti Bio Ventures reported a Net Profit after tax of INR 61.24 Lakhs for the quarter ended June 30, 2026.
What is the proposed new name for Arunjyoti Bio Ventures?
The company's Board has proposed changing the name from “Arunjyoti Bio Ventures Limited” to “Pasura Industries Limited,” subject to member approval.
What is the revised monthly remuneration for Mr. Badari Narayana Murthy Pabbathi?
The revised remuneration for Mr. Badari Narayana Murthy Pabbathi, Whole-time Director, is Rs. 8,00,000 per month plus Leave Travel allowance of up to Rs. 10,00,000 per annum.
What amount of excess managerial remuneration waiver is sought for FY26?
The company is seeking member approval for the waiver of recovery of excess managerial remuneration of Rs. 25.19 Lakhs in aggregate for the Financial Year 2025-26.
When is Arunjyoti Bio Ventures' 40th Annual General Meeting scheduled?
The 40th Annual General Meeting for FY 2025-26 is scheduled to be held on Wednesday, August 12, 2026, at 11:00 AM.
Questions based on this BSE filing only. For information purposes.